EXANE DERIVATIVES - AMAG PHARMACEUTICALS INC ownership

AMAG PHARMACEUTICALS INC's ticker is AMAG and the CUSIP is 00163U106. A total of 190 filers reported holding AMAG PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 2.17 and the average weighting 0.1%.

Quarter-by-quarter ownership
EXANE DERIVATIVES ownership history of AMAG PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2018$33,501,000
-38.7%
2,206
-19.1%
0.01%
-40.0%
Q3 2018$54,640,000
+15.1%
2,726
+15.7%
0.01%
+25.0%
Q2 2018$47,457,000
+35.1%
2,356
+22.4%
0.01%
+14.3%
Q1 2018$35,121,000
-13.0%
1,925
-36.9%
0.01%0.0%
Q4 2017$40,389,000
-85.8%
3,049
-80.2%
0.01%
-86.8%
Q3 2017$284,192,000
-26.5%
15,406
-26.7%
0.05%
-36.1%
Q2 2017$386,450,000
-3.9%
21,007
+17.7%
0.08%
-8.8%
Q1 2017$402,305,000
-40.4%
17,843
-8.0%
0.09%
-31.6%
Q4 2016$674,749,000
+21.5%
19,392
-14.4%
0.13%
+60.2%
Q3 2016$555,425,000
+18.1%
22,663
+15.3%
0.08%
+6.4%
Q2 2016$470,309,000
+3.7%
19,663
+1.4%
0.08%
+30.0%
Q1 2016$453,745,000
+9.1%
19,391
+40.7%
0.06%
+5.3%
Q4 2015$415,930,00013,7780.06%
Other shareholders
AMAG PHARMACEUTICALS INC shareholders Q3 2018
NameSharesValueWeighting ↓
HUNTINGTON NATIONAL BANK 1$140.00%
View complete list of AMAG PHARMACEUTICALS INC shareholders